نتایج جستجو برای: tbi / bucy regimens

تعداد نتایج: 40000  

Journal: :international journal of hematology-oncology and stem cell research 0
mohammad vaezi hematologist- oncologist, hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran cyrous gharib hematologist- oncologist, gilan university of medical sciences, gilan, iran maryam souri 3hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh professor of medicine, hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

background: hematopoietic stem cell transplantation (hsct) is currently the only curative treatment for acute leukemia. as hsct improves the long-term survival, it is necessary to assess the late-onset complications affecting the quality of life following hsct. subjects and methods: the study included 122 patients (65 male, 57 female) with leukemia (72 aml and 50 all) who received transplants f...

Journal: :Blood 2013
Edward A Copelan Betty K Hamilton Belinda Avalos Kwang Woo Ahn Brian J Bolwell Xiaochun Zhu Mahmoud Aljurf Koen van Besien Christopher Bredeson Jean-Yves Cahn Luciano J Costa Marcos de Lima Robert Peter Gale Gregory A Hale Joerg Halter Mehdi Hamadani Yoshihiro Inamoto Rammurti T Kamble Mark R Litzow Alison W Loren David I Marks Eduardo Olavarria Vivek Roy Mitchell Sabloff Bipin N Savani Matthew Seftel Harry C Schouten Celalettin Ustun Edmund K Waller Daniel J Weisdorf Baldeep Wirk Mary M Horowitz Mukta Arora Jeff Szer Jorge Cortes Matt E Kalaycio Richard T Maziarz Wael Saber

Cyclophosphamide combined with total body irradiation (Cy/TBI) or busulfan (BuCy) are the most widely used myeloablative conditioning regimens for allotransplants. Recent data regarding their comparative effectiveness are lacking. We analyzed data from the Center for International Blood and Marrow Transplant Research for 1230 subjects receiving a first hematopoietic cell transplant from a human...

Journal: :Blood 2007
Chunkang Chang Barry E Storer Bart L Scott Eileen M Bryant Howard M Shulman Mary E Flowers Brenda M Sandmaier Robert P Witherspoon Richard A Nash Jean E Sanders Antonio Bedalov John A Hansen Bruce E Clurman Rainer Storb Frederick R Appelbaum H Joachim Deeg

We analyzed outcomes after hematopoietic cell transplantation (HCT) in 257 patients, 3 to 72.7 years old (median, 43 y), with secondary myelodysplastic syndrome (MDS) including those with transformation to acute myeloid leukemia (tAML). Conditioning regimens included high-dose total-body irradiation (TBI)/chemotherapy (n = 83); busulfan (BU)/cyclophosphamide (CY) (BUCY, n = 122; with BU targeti...

2016
Ting Yang Qiaoxian Lin Jinhua Ren Ping Chen Xiaohong Yuan Xiaofeng Luo Tingbo Liu Jing Zheng Zhihong Zheng Xiaoyun Zheng Xinji Chen Langhui Zhang Hao Zheng Zaisheng Chen Xueling Hua Shaohua Le Jian Li Zhizhe Chen Jianda Hu

Haplo-HSCT has been used when HLA-matched siblings are not available. Conditioning regimens aim to reduce tumor burden prior to HSCT and provide sufficient immunoablation. We report the outcome of haplo-HSCT in 63 consecutive patients from 2/2013 to 12/2015 (19 females/44 males) with high-risk or relapsed/refractory hematological malignancies (n=29-AML; 8-sAML; 19-ALL; 5-advanced-MDS; 2-CML-BC)...

Journal: :Blood advances 2017
Lawrence Faulkner Cornelio Uderzo Sadaf Khalid Priya Marwah Rajpreet Soni Naila Yaqub Samina Amanat Itrat Fatima Sarah Khan Gilani Tatheer Zahra Stalin Ramprakash Lallindra Gooneratne Ruwangi Dissanayake Senani Williams Wasantha Rathnayake Reshma Srinivas Amit Sedai Ankita Kumari Lailith Parmar Rakesh Dhanya Rajat Kumar Agarwal

Matched-related bone marrow transplantation (BMT) may cure >80% of low-risk children with severe thalassemia (ST). Very long-term follow-up studies have shown how the standard busulfan-cyclophosphamide (BuCy) regimen may be associated with normalization of health-related quality of life, no second malignancies in the absence of chronic graft-versus-host disease, and fertility preservation in ma...

Journal: :The oncologist 1999
C Aristei A Tabilio

We review the rationale for, and the results of, clinical trials on chemoradiotherapy-based pretransplant regimens for non-Hodgkin's lymphomas, Hodgkin's disease and multiple myeloma. What clearly emerges from this review is the lack of any conclusive evidence that total-body irradiation (TBI)-containing regimens are better than chemotherapy alone in diseases which are considered to be radiosen...

Journal: :Blood 1994
C Q Xun J S Thompson C D Jennings S A Brown M B Widmer

In a previous study, we found that total body irradiation (TBI) was essential to induce acute graft-versus-host disease (GVHD) after allogeneic H-2-incompatible splenocyte (SP) transplantation in SCID mice. SCID mice (H-2d) conditioned with cyclophosphamide and transplanted intravenously (IV) with 5 x 10(7) C57BL/6 (H-2b) SP developed chronic GVHD within 3 months posttransplant without any evid...

Journal: :Haematologica 2000
E Granados R de La Cámara L Madero M A Díaz P Martín-Regueira J L Steegmann R Arranz A Figuera J M Fernández-Rañada

BACKGROUND AND OBJECTIVES There is only limited experience with conditioning regimens based on busulfan for patients with acute lymphoblastic leukemia (ALL). Therefore, the aim of this study was to compare the event-free survival (EFS), transplant-related mortality (TRM) and the probability of relapse (PR) of patients undergoing hematopoietic cell transplantation (HCT) for ALL conditioned with ...

Journal: :AJNR. American journal of neuroradiology 2004
Walter S Bartynski Zella R Zeigler Richard K Shadduck John Lister

BACKGROUND AND PURPOSE Transplantation conditioning regimens have been shown to affect the brain imaging appearance in patients with cyclosporine or FK-506 neurotoxicity. We assessed whether the occurrence of neurotoxicity was affected by the choice of conditioning regimen used before allogeneic bone marrow transplantation (allo-BMT). METHODS An allo-BMT was performed in 290 patients conditio...

Journal: :Cancer research 1983
A Hagenbeek A C Martens

The efficacy of current clinical leukemia treatment with high-dose cyclophosphamide, supralethal total-body irradiation (TBI), and bone marrow transplantation was evaluated in a rat model for human acute myelocytic leukemia. In rats, both at an early stage of disease and in an advanced stage after remission-induction with 1-beta-D-arabinofuranosylcytosine, treatment with cyclophosphamide (100 m...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید